Surgical Science Sweden AB (publ) (STO:SUS)

STO:SUS Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	612.89	968.16	634.37	433.73	316.68	87.16
Cash & Short-Term Investments	612.89	968.16	634.37	433.73	316.68	87.16
Cash Growth	-7.02%	52.62%	46.26%	36.96%	263.34%	25.92%
Accounts Receivable	148.43	136.7	110.6	176.31	110.65	18.59
Other Receivables	56.52	121.44	81.11	67.81	69.14	13.48
Receivables	204.95	258.14	191.71	244.13	179.79	32.07
Inventory	187.88	179.58	154.45	134.88	113.11	12.46
Prepaid Expenses	103.74	20.13	10.67	13.63	7.33	1.7
Other Current Assets	-	0	-	-	-	-
Total Current Assets	1,109	1,426	991.19	826.37	616.91	133.39
Property, Plant & Equipment	111.48	101.53	76.62	51.36	38.39	8.55
Goodwill	3,335	3,616	3,329	3,444	3,019	260.49
Other Intangible Assets	318.83	311.91	286.57	301.02	274.03	62.9
Long-Term Deferred Tax Assets	14.52	16.33	14.84	22.16	24.6	6.72
Other Long-Term Assets	8.1	8.05	4.77	4.37	4.97	0.21
Total Assets	4,897	5,480	4,703	4,650	3,978	472.27
Accounts Payable	-	58.45	41.29	65.69	34.37	2.3
Accrued Expenses	-	58.12	47.34	44.27	104.18	9.87
Short-Term Debt	1.64	-	-	-	-	-
Current Income Taxes Payable	-	51.44	31.03	13.9	5.49	6.66
Current Unearned Revenue	-	66.83	72.89	70.65	16.95	4.94
Other Current Liabilities	283.52	277.89	42.39	111.4	71.39	7.51
Total Current Liabilities	285.16	512.72	234.94	305.91	232.38	31.28
Long-Term Leases	-	56.94	40.02	14.68	12.07	2.32
Long-Term Unearned Revenue	-	19.47	20.29	27.62	20.49	-
Long-Term Deferred Tax Liabilities	-	43.55	45	51.51	48.51	9.66
Other Long-Term Liabilities	135.33	18.36	17.21	13.4	79.61	1.97
Total Liabilities	420.5	651.03	357.46	413.11	393.06	45.22
Common Stock	2.55	2.55	2.55	2.54	2.54	1.73
Additional Paid-In Capital	3,398	3,398	3,398	3,379	3,379	425.62
Retained Earnings	672.65	639.41	507.76	273.79	85.82	-0.43
Comprehensive Income & Other	403.33	788.56	436.78	581.14	117.73	0.14
Shareholders' Equity	4,477	4,829	4,345	4,236	3,585	427.05
Total Liabilities & Equity	4,897	5,480	4,703	4,650	3,978	472.27
Total Debt	1.64	56.94	40.02	14.68	12.07	2.32
Net Cash (Debt)	611.25	911.22	594.34	419.05	304.61	84.84
Net Cash Growth	-7.27%	53.31%	41.83%	37.57%	259.05%	26.68%
Net Cash Per Share	11.98	17.86	11.67	8.23	7.14	2.47
Filing Date Shares Outstanding	51.03	51.03	51.03	50.8	50.8	34.49
Total Common Shares Outstanding	51.03	51.03	51.03	50.8	50.8	34.49
Working Capital	824.29	913.29	756.26	520.46	384.53	102.12
Book Value Per Share	87.73	94.63	85.16	83.39	70.57	12.38
Tangible Book Value	823.06	900.89	729.96	491.14	291.81	103.65
Tangible Book Value Per Share	16.13	17.66	14.31	9.67	5.74	3.00
Machinery	-	186.66	132.67	91.23	58.54	16.19

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.